Literature DB >> 32419728

Interventional Management of Head and Neck Tumors.

Mudassar Kamran1, Adam N Wallace2, Amole Adewumi1.   

Abstract

Advancements in medical imaging and device technology allow minimal invasive procedures for the diagnosis and treatment of various disorders. For the management of tumors in head and neck region, these image-guided interventions play essential role in the often used multidisciplinary approach. Tissue sampling under ultrasound or computed tomography guidance is generally the first step to reach a pathological diagnosis. For head and neck tumors with high vascularity, embolization using particulate matter, liquid embolic agents, or coils is used to achieve successful tumor resection with minimal blood loss. Hemorrhage related to head and neck tumors can be evaluated and managed with endovascular techniques with minimal morbidity and mortality. Intra-arterial chemotherapy, radiofrequency ablation, and cryotherapy are new techniques for the management of advanced head and neck cancer which may serve as an alternative to achieve locoregional control and survival when curative resection may not be feasible. © Thieme Medical Publishers.

Entities:  

Keywords:  endovascular technique; head and neck tumors; image-guided interventions; interventional radiology; intra-arterial chemotherapy; squamous cell carcinoma

Year:  2020        PMID: 32419728      PMCID: PMC7224979          DOI: 10.1055/s-0040-1709157

Source DB:  PubMed          Journal:  Semin Intervent Radiol        ISSN: 0739-9529            Impact factor:   1.513


  85 in total

Review 1.  Principles of and advances in percutaneous ablation.

Authors:  Muneeb Ahmed; Christopher L Brace; Fred T Lee; S Nahum Goldberg
Journal:  Radiology       Date:  2011-02       Impact factor: 11.105

2.  Antimetabolite-metabolite cancer chemotherapy using continuous intra-arterial methotrexate with intermittent intramuscular citrovorum factor. Method of therapy.

Authors:  J K DUFF; R D SULLIVAN; E MILLER; A H ULM; B D CLARKSON; P CLIFFORD
Journal:  Cancer       Date:  1961 Jul-Aug       Impact factor: 6.860

Review 3.  Interventional neuroradiology of the head and neck.

Authors:  D Gandhi; J J Gemmete; S A Ansari; S K Gujar; S K Mukherji
Journal:  AJNR Am J Neuroradiol       Date:  2008-09-10       Impact factor: 3.825

4.  Usefulness of cutting needle biopsy in recurrent and advanced staged head and neck malignancies in a palliative setting.

Authors:  G J Ridder; J Pfeiffer
Journal:  Support Care Cancer       Date:  2007-03-21       Impact factor: 3.603

Review 5.  Head and neck cancer.

Authors:  E E Vokes; R R Weichselbaum; S M Lippman; W K Hong
Journal:  N Engl J Med       Date:  1993-01-21       Impact factor: 91.245

6.  Stages III and IV squamous cell carcinoma of the mouth: three-year experience with superselective intraarterial chemotherapy using cisplatin prior to definitive treatment.

Authors:  T Hirai; Y Korogi; S Hamatake; R Nishimura; Y Baba; M Takahashi; Y Uji; A Taen
Journal:  Cardiovasc Intervent Radiol       Date:  1999 May-Jun       Impact factor: 2.740

7.  Brain abscess formation: a delayed complication of carotid blowout syndrome treated by self-expandable stent-graft.

Authors:  F-C Chang; J-F Lirng; S-K Tai; C-B Luo; M M H Teng; C-Y Chang
Journal:  AJNR Am J Neuroradiol       Date:  2006-08       Impact factor: 3.825

8.  Targeted chemoradiation for advanced head and neck cancer: analysis of 213 patients.

Authors:  K T Robbins; P Kumar; F S Wong; W F Hartsell; P Flick; R Palmer; A B Weir; H B Neill; T Murry; R Ferguson; C Hanchett; F Vieira; A Bush; S B Howell
Journal:  Head Neck       Date:  2000-10       Impact factor: 3.147

Review 9.  Renal Ablation Techniques: State of the Art.

Authors:  Luke J Higgins; Kelvin Hong
Journal:  AJR Am J Roentgenol       Date:  2015-07-23       Impact factor: 3.959

10.  High-dose superselective intra-arterial cisplatin and concomitant radiation (RADPLAT) for advanced head and neck cancer.

Authors:  Alfons J M Balm; Coen R N Rasch; Jan H Schornagel; Frans J M Hilgers; Ronald B Keus; Leo Schultze-Kool; Annemieke H Ackerstaff; Wim Busschers; I Bing Tan
Journal:  Head Neck       Date:  2004-06       Impact factor: 3.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.